Background A rapid increase in incidence of the SARS-CoV-2 Omicron variant (sub-lineage
BA.1) occurred in France in December 2021, while the Delta variant was prevailing since …

Objectives We aimed to investigate the first Omicron cases detected in France in order to
assess case characteristics and provide supporting information on the possible impact of this …

The COVID-19 pandemic has demonstrated the need for massively-parallel, cost-effective
tests monitoring viral spread. Here we present SARSeq, saliva analysis by RNA sequencing, …

Lassa fever is a major threat in Western Africa. The large number of people living at risk for
this disease calls for the development of a vaccine against Lassa virus (LASV). We generated …

Background Lassa fever is a viral haemorrhagic fever endemic in parts of west Africa. New
treatments are needed to decrease mortality, but pretrial reference data on the disease …

BACKGROUND. The pathogenesis of Ebola virus (EBOV) disease (EVD) is poorly characterized.
The establishment of well-equipped diagnostic laboratories close to Ebola treatment …

This cohort study evaluated the protection against symptomatic Omicron BA.5 infection
conferred by the Pfizer-BioNTech Original/BA.4-5 bivalent vaccine compared to mRNA Original …

BACKGROUND. The West African Ebola virus epidemic from 2014–2016 highlighted the lack
of knowledge about the pathogenicity of the virus and the factors responsible for outcome. …

Lassa virus (LASV) is endemic in West Africa and induces a viral hemorrhagic fever (VHF)
with up to 30% lethality among clinical cases. The mechanisms involved in control of Lassa …

In face of evidence of rapid waning of vaccine effectiveness against Omicron and its sub-lineages,
a second booster with mRNA vaccines was recommended for the most vulnerable in …